Surgical Science Sweden AB (publ) (STO:SUS)
Sweden · Delayed Price · Currency is SEK 28.54
-0.76 (-2.59%)
Jan 21, 2026, 12:49 PM CET
STO:SUS Market Cap
STO:SUS has a market cap or net worth of 1.5 billion as of January 21, 2026. Its market cap has decreased by -81.64% in one year.
Market Cap
1.50B
Enterprise Value
899.31M
Revenue
975.04M
Ranking
n/a
PE Ratio
21.41
Stock Price
28.54
Market Cap Chart
Since June 19, 2017, STO:SUS's market cap has increased from 279.67M to 1.50B, an increase of 434.58%. That is a compound annual growth rate of 21.54%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 1.49B | -10.03% |
| Dec 30, 2025 | 1.66B | -79.15% |
| Dec 30, 2024 | 7.95B | -14.58% |
| Dec 29, 2023 | 9.31B | 11.30% |
| Dec 30, 2022 | 8.37B | -41.49% |
| Dec 30, 2021 | 14.30B | 343.39% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 19, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Swedish Orphan Biovitrum AB | 112.22B |
| Getinge AB | 57.22B |
| Sectra AB | 43.89B |
| BioArctic AB | 43.86B |
| Egetis Therapeutics AB | 1.75B |
| Devyser Diagnostics AB | 1.74B |
| Diamyd Medical AB | 1.67B |
| EQL Pharma AB | 1.65B |